Cancer Letters is a high-volume Elsevier journal for basic and translational cancer biology, with an emphasis on experimental targeted therapies. Read by laboratory cancer researchers.
Cancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology, with Special Issues on topical areas of cancer research. Areas of interest listed on its aims page include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis and chemoprevention, with emphasis on experimental therapeutics and targeted therapies for personalised cancer medicine. Published by Elsevier since 1975 (originally Elsevier/North-Holland), it appears twenty-six times a year. The ScienceDirect page states that the journal supports open access, so it runs a hybrid model with subscription content and an open access option. Indexed in MEDLINE.
Academician who presides over the China Anti-Cancer Association, China's national oncology society with branches in every province and around 260,000 individual members.
Vasyl F. Chekhun represents R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology in the Organisation of European Cancer Institutes, which lists the centre among its members in Ukraine.
Shares Targeted therapy, PubMed & Europe PMC.
Shares Metastasis, PubMed & Europe PMC.
Shares Metastasis, PubMed & Europe PMC.
Shares Metastasis, PubMed & Europe PMC.
Shares Metastasis, PubMed & Europe PMC.
Shares Fan Daiming, PubMed & Europe PMC.
Shares Fan Daiming, PubMed & Europe PMC.